Insider · CIK 0001834418
Veronique Lecault
Files at ABCL (AbCellera Biologics Inc.). First filing -, latest -.
In brief
Veronique Lecault files SEC Form 4 as COO and director at ABCL (AbCellera Biologics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Veronique Lecault has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | ABCL AbCellera Biologics Inc. | AGrant or award Share option (right to buy)derivative | +539,265 | $0.00 | $0 | 5,201,069 | Jan 5, 2026 |
| Jan 1, 2025 | ABCL AbCellera Biologics Inc. | AGrant or award Share option (right to buy)derivative | +832,033 | $0.00 | $0 | 4,661,804 | Jan 3, 2025 |
Questions about Veronique Lecault
Answered from the filings on this page, as of the latest one.
Is Veronique Lecault buying or selling?
Veronique Lecault has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Veronique Lecault's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Veronique Lecault has 0.
Where does Veronique Lecault file Form 4?
Veronique Lecault has filed Form 4 at ABCL (AbCellera Biologics Inc.) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.